Moderna (MRNA) has had the lowest return this year by a US stock in the S&P 500 (GSPC), returning -58.1%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Moderna (MRNA) | 2024 | -58.11% |
Walgreens Boots Alliance (WBA) | 2024 | -57.75% |
Intel (INTC) | 2024 | -57.1% |
Celanese (CE) | 2024 | -54.73% |
Dollar Tree (DLTR) | 2024 | -50.76% |
Enphase Energy (ENPH) | 2024 | -45.19% |
Dollar General (DG) | 2024 | -43.88% |
Estee Lauder Companies (EL) | 2024 | -43.65% |
Humana (HUM) | 2024 | -42.91% |
Biogen (BIIB) | 2024 | -41.57% |
CVS Health (CVS) | 2024 | -38.47% |
DexCom (DXCM) | 2024 | -37.95% |
APA (APA) | 2024 | -37.21% |
Qorvo (QRVO) | 2024 | -36.8% |
Aptiv (APTV) | 2024 | -34.91% |
Boeing (BA) | 2024 | -32.69% |
Microchip Technology (MCHP) | 2024 | -32.22% |
Albemarle (ALB) | 2024 | -29.31% |
AES (AES) | 2024 | -28.48% |
Teleflex (TFX) | 2024 | -27.85% |
Nucor (NUE) | 2024 | -27.81% |
Nike (NKE) | 2024 | -27.02% |
Devon Energy (DVN) | 2024 | -26.05% |
Archer-Daniels-Midland (ADM) | 2024 | -25.98% |
Amentum (AMTM) | 2024 | -25.69% |
